Evidence map›Paper›PMID 37881427›Full record

ArticleFrontiers in immunology2023

Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.

Julia C Berentschot, Hemmo A Drexhage, Daniel G Aynekulu Mersha, Annemarie J M Wijkhuijs, Corine H GeurtsvanKessel, Marion P G Koopmans, Jolanda J C Voermans, Rudi W Hendriks, Nicole M A Nagtzaam, Maaike de Bie and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Blood Biomarkers of Long COVID: A Systematic Review.Molecular diagnosis & therapy · 2024
    Pooled it
  4. Human brain matters: Navigating the neuropathology of COVID-19.Brain pathology (Zurich, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Observational
  8. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  9. Review
  10. CD169Frontiers in cellular and infection microbiology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Constraints and tunability of antigen-agnostic memory durability.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Julia C BerentschotDepartment of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Hemmo A DrexhageDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Daniel G Aynekulu MershaDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Annemarie J M WijkhuijsDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Corine H GeurtsvanKesselDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Marion P G KoopmansDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Jolanda J C VoermansDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Rudi W HendriksDepartment of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Nicole M A NagtzaamLaboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Maaike de BieLaboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Majanka H Heijenbrok-KalDepartment of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
L Martine BekDepartment of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Gerard M RibbersDepartment of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Rita J G van den Berg-EmonsDepartment of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Joachim G J V AertsDepartment of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Willem A DikLaboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Merel E HellemonsDepartment of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Erasmus MC · NLCodarts Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Many patients with SARS-CoV-2 infection develop long COVID with fatigue as one of the most disabling symptoms. We performed clinical and immune profiling of fatigued and non-fatigued long COVID patients and age- and sex-matched healthy controls (HCs). Methods: Long COVID symptoms were assessed using patient-reported outcome measures, including the fatigue assessment scale (FAS, scores ≥22 denote fatigue), and followed up to one year after hospital discharge. We assessed inflammation-related genes in circulating monocytes, serum levels of inflammation-regulating cytokines, and leukocyte and lymphocyte subsets, including major monocyte subsets and senescent T-lymphocytes, at 3-6 months post-discharge. Results: We included 37 fatigued and 36 non-fatigued long COVID patients and 42 HCs. Fatigued long COVID patients represented a more severe clinical profile than non-fatigued patients, with many concurrent symptoms (median 9 [IQR 5.0-10.0] vs 3 [1.0-5.0] symptoms, p<0.001), and signs of cognitive failure (41%) and depression (>24%). Immune abnormalities that were found in the entire group of long COVID patients were low grade inflammation (increased inflammatory gene expression in monocytes, increased serum pro-inflammatory cytokines) and signs of T-lymphocyte senescence (increased exhausted CD8 Conclusion: Long COVID with fatigue is associated with many concurrent and persistent symptoms lasting up to one year after hospitalization. Increased fatigue severity associated with stronger signs of monocyte activation in long COVID patients and potentially point in the direction of monocyte-endothelial interaction. These abnormalities were present against a background of immune abnormalities common to the entire group of long COVID patients.

Indexed as

COVID-19T-LymphocytesAftercareCytokinesFatigueHumansInflammationMonocytesPatient DischargePost-Acute COVID-19 SyndromeSARS-CoV-2CytokinesCOVID-19fatigueinflammationlong COVIDmonocytesT-lymphocytes

Identifiers

PMID37881427
PMCPMC10597688
OpenAlexW4387514177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.